USE OF THE NEW ANTIEPILEPTIC DRUG PERAMPANEL (FYCOMPA) IN THE TREATMENT OF EPILEPSY: A REVIEW OF FOREIGN LITERATURE

Despite a considerable advance made in epileptology, resistant epilepsies are about 30% among all epilepsy types particularly in patients with focal seizures. In these cases, there is hope for the success of neurosurgical treatment and the synthesis of new antiepileptic drugs (AEDs). The authors pro...

Full description

Bibliographic Details
Main Authors: O. A. Pylaeva, K. Yu. Mukhin
Format: Article
Language:Russian
Published: ABV-press 2015-04-01
Series:Russkij Žurnal Detskoj Nevrologii
Subjects:
Online Access:https://rjdn.abvpress.ru/jour/article/view/29
id doaj-0411fc63e4de42aba66c40b43926af44
record_format Article
spelling doaj-0411fc63e4de42aba66c40b43926af442021-07-29T08:20:40ZrusABV-pressRusskij Žurnal Detskoj Nevrologii2073-88032412-91782015-04-0193364210.17650/2073-8803-2014-9-3-36-4223USE OF THE NEW ANTIEPILEPTIC DRUG PERAMPANEL (FYCOMPA) IN THE TREATMENT OF EPILEPSY: A REVIEW OF FOREIGN LITERATUREO. A. Pylaeva0K. Yu. Mukhin1Svt. Luka’s Institute of Child Neurology and Epilepsy, MoscowSvt. Luka’s Institute of Child Neurology and Epilepsy, MoscowDespite a considerable advance made in epileptology, resistant epilepsies are about 30% among all epilepsy types particularly in patients with focal seizures. In these cases, there is hope for the success of neurosurgical treatment and the synthesis of new antiepileptic drugs (AEDs). The authors provide a review of the literature dealing the new AED perampanel (Fycompa) and consider its mechanism of action, pharmacokinetics, clinical and postmarketing trials of its efficacy, tolerability, and safety. Based on the data available in the literature, it may be concluded that parampanel is a promising highly effective and well tolerated AED to treat partial and secondary generalized seizures.https://rjdn.abvpress.ru/jour/article/view/29epilepsyantiepileptic drugsperampanel (fycompa)efficacytolerability
collection DOAJ
language Russian
format Article
sources DOAJ
author O. A. Pylaeva
K. Yu. Mukhin
spellingShingle O. A. Pylaeva
K. Yu. Mukhin
USE OF THE NEW ANTIEPILEPTIC DRUG PERAMPANEL (FYCOMPA) IN THE TREATMENT OF EPILEPSY: A REVIEW OF FOREIGN LITERATURE
Russkij Žurnal Detskoj Nevrologii
epilepsy
antiepileptic drugs
perampanel (fycompa)
efficacy
tolerability
author_facet O. A. Pylaeva
K. Yu. Mukhin
author_sort O. A. Pylaeva
title USE OF THE NEW ANTIEPILEPTIC DRUG PERAMPANEL (FYCOMPA) IN THE TREATMENT OF EPILEPSY: A REVIEW OF FOREIGN LITERATURE
title_short USE OF THE NEW ANTIEPILEPTIC DRUG PERAMPANEL (FYCOMPA) IN THE TREATMENT OF EPILEPSY: A REVIEW OF FOREIGN LITERATURE
title_full USE OF THE NEW ANTIEPILEPTIC DRUG PERAMPANEL (FYCOMPA) IN THE TREATMENT OF EPILEPSY: A REVIEW OF FOREIGN LITERATURE
title_fullStr USE OF THE NEW ANTIEPILEPTIC DRUG PERAMPANEL (FYCOMPA) IN THE TREATMENT OF EPILEPSY: A REVIEW OF FOREIGN LITERATURE
title_full_unstemmed USE OF THE NEW ANTIEPILEPTIC DRUG PERAMPANEL (FYCOMPA) IN THE TREATMENT OF EPILEPSY: A REVIEW OF FOREIGN LITERATURE
title_sort use of the new antiepileptic drug perampanel (fycompa) in the treatment of epilepsy: a review of foreign literature
publisher ABV-press
series Russkij Žurnal Detskoj Nevrologii
issn 2073-8803
2412-9178
publishDate 2015-04-01
description Despite a considerable advance made in epileptology, resistant epilepsies are about 30% among all epilepsy types particularly in patients with focal seizures. In these cases, there is hope for the success of neurosurgical treatment and the synthesis of new antiepileptic drugs (AEDs). The authors provide a review of the literature dealing the new AED perampanel (Fycompa) and consider its mechanism of action, pharmacokinetics, clinical and postmarketing trials of its efficacy, tolerability, and safety. Based on the data available in the literature, it may be concluded that parampanel is a promising highly effective and well tolerated AED to treat partial and secondary generalized seizures.
topic epilepsy
antiepileptic drugs
perampanel (fycompa)
efficacy
tolerability
url https://rjdn.abvpress.ru/jour/article/view/29
work_keys_str_mv AT oapylaeva useofthenewantiepilepticdrugperampanelfycompainthetreatmentofepilepsyareviewofforeignliterature
AT kyumukhin useofthenewantiepilepticdrugperampanelfycompainthetreatmentofepilepsyareviewofforeignliterature
_version_ 1721256422807699456